TUMI THERAPEUTICS: what changed
TUMI THERAPEUTICS
Largest movements
- Receivables within one year +€43,509
up €43,509 (+108%), from €40,139 to €83,649
of which Other amounts receivable: +€43,170
- Cash +€41,989
up €41,989 (+14.5%), from €289,578 to €331,567
mainly Accrued charges and deferred income (+€106,454) and Net result for the year (+€39,320)
- Accrued charges and deferred income +€106,454
up €106,454 (+310%), from €34,309 to €140,763
- Trade debts -€73,329
down €73,329 (-77.9%), from €94,118 to €20,789
- Reserves +€39,320
up €39,320 (+32.3%), from €121,650 to €160,969
of which Distributable reserves: +€39,320
- Tax, wage and social debts +€11,613
up €11,613 (+76.8%), from €15,124 to €26,737
- Gross operating margin +€41,996
up €41,996 (+26.3%), from €159,889 to €201,885
- Staff costs +€9,022
up €9,022 (+6.7%), from €134,437 to €143,460
- Taxes +€7,401
up €7,401 (+254%), from €2,914 to €10,315
- Financial charges -€4,129
down €4,129 (-34.7%), from €11,913 to €7,784
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €341,991 | €424,011 | +€82,020 | +24.0% |
| Fixed assets | 21/28 | €12,226 | €8,611 | -€3,615 | -29.6% |
| Intangible fixed assets | 21 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €12,226 | €8,611 | -€3,615 | -29.6% |
| Plant, machinery and equipment | 23 | €9,415 | €7,001 | -€2,414 | -25.6% |
| Furniture and vehicles | 24 | €2,811 | €1,610 | -€1,200 | -42.7% |
| Current assets | 29/58 | €329,765 | €415,400 | +€85,635 | +26.0% |
| Amounts receivable within one year | 40/41 | €40,139 | €83,649 | +€43,509 | +108% |
| Trade receivables | 40 | €23,772 | €24,111 | +€340 | +1.4% |
| Other amounts receivable | 41 | €16,368 | €59,537 | +€43,170 | +264% |
| Cash at bank and in hand | 54/58 | €289,578 | €331,567 | +€41,989 | +14.5% |
| Deferred charges and accrued income | 490/1 | €48 | €184 | +€136 | +284% |
| Total equity and liabilities | 10/49 | €341,991 | €424,011 | +€82,020 | +24.0% |
| Equity | 10/15 | €122,589 | €161,909 | +€39,320 | +32.1% |
| Contributions | 10/11 | €939 | €939 | = | 0.0% |
| Reserves | 13 | €121,650 | €160,969 | +€39,320 | +32.3% |
| Non-distributable reserves | 130/1 | €4,372 | €4,372 | = | 0.0% |
| Reserves not available under the articles | 1311 | €4,372 | €4,372 | = | 0.0% |
| Distributable reserves | 133 | €117,278 | €156,598 | +€39,320 | +33.5% |
| Amounts payable | 17/49 | €219,402 | €262,102 | +€42,701 | +19.5% |
| Amounts payable within one year | 42/48 | €185,093 | €121,339 | -€63,754 | -34.4% |
| Financial debts | 43 | €5,079 | €3,373 | -€1,705 | -33.6% |
| Credit institutions | 430/8 | €5,079 | €3,373 | -€1,705 | -33.6% |
| Trade debts | 44 | €94,118 | €20,789 | -€73,329 | -77.9% |
| Suppliers | 440/4 | €94,118 | €20,789 | -€73,329 | -77.9% |
| Taxes, remuneration and social security | 45 | €15,124 | €26,737 | +€11,613 | +76.8% |
| Remuneration and social security | 454/9 | €15,124 | €26,737 | +€11,613 | +76.8% |
| Other amounts payable | 47/48 | €70,773 | €70,440 | -€333 | -0.5% |
| Accrued charges and deferred income | 492/3 | €34,309 | €140,763 | +€106,454 | +310% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €134,437 | €143,460 | +€9,022 | +6.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,491 | €3,615 | +€123 | +3.5% |
| Other operating charges | 640/8 | €817 | €61 | -€756 | -92.5% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €159,889 | €201,885 | +€41,996 | +26.3% |
| Operating profit (loss) | 9901 | €21,143 | €54,749 | +€33,606 | +159% |
| Financial income | 75/76B | €2,709 | €2,670 | -€39 | -1.5% |
| Recurring financial income | 75 | €2,709 | €2,670 | -€39 | -1.5% |
| Financial charges | 65/66B | €11,913 | €7,784 | -€4,129 | -34.7% |
| Recurring financial charges | 65 | €11,913 | €7,784 | -€4,129 | -34.7% |
| Profit (loss) for the period before taxes | 9903 | €11,939 | €49,635 | +€37,695 | +316% |
| Income taxes | 67/77 | €2,914 | €10,315 | +€7,401 | +254% |
| Profit (loss) for the period | 9904 | €9,025 | €39,320 | +€30,295 | +336% |
| Profit (loss) for the period to be appropriated | 9905 | €9,025 | €39,320 | +€30,295 | +336% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.